Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-23 · accession 0001140361-22-024166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-27 | 2022-06-23 | ATRA | Gallagher Carol Giltner | Dir | A - Grant | $0.00 | +20.5K | 132.4K | +18% | $0 |
| D | 2022-06-27 | 2022-06-23 | ATRA | Gallagher Carol Giltner | Dir | A - Grant | $0.00 | +31.5K | 31.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-23 | A | A | 20,500 | $0.00 | 132,418 | D | — | — | (F1) These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. (F2) The amount of securities beneficially owned by the reporting person shown here corrects an inadvertent understatement of 100 shares in a prior Form 4. |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-06-23 | A | A | 31,500 | $0.00 | 31,500 | D | $7.35 · — to 2032-06-22 | 31,500 Common Stock | (F3) The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |